Teva- Pharmaceutical Industries Ltd. Overview
Teva- Pharmaceutical Industries Ltd. Target Price
Analysts' 12-month price predictions for TEVA.
Share Price
$16.85
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-12-18 | UBSAshwani Verma | $28 |  66.2% upside |  |
| 2024-12-18 | BarclaysBalaji Prasad | $28 | 66.2% upside | |
| 2024-10-23 | BarclaysBalaji Prasad | $25 | 48.4% upside | |
| 2024-10-01 | Bank of America SecuritiesJason Gerberry | $22 | 30.6% upside | |
| 2024-09-03 | UBSAshwani Verma | $26 | 54.3% upside | |
| 2024-08-28 | Piper SandlerDavid Amsellem | $23 | 36.5% upside | |
| 2024-08-01 | BarclaysBalaji Prasad | $22 | 30.6% upside | |
| 2024-07-10 | Argus ResearchJasper Hellweg | $20 | 18.7% upside | |
| 2024-07-10 | UBSAshwani Verma | $24 | 42.4% upside | |
| 2024-06-05 | BarclaysBalaji Prasad | $21 | 24.6% upside | |
| 2024-05-23 | BarclaysBalaji Prasad | $20 | 18.7% upside | |
| 2024-05-13 | Piper SandlerDavid Amsellem | $20 | 18.7% upside | |
| 2024-02-12 | Piper SandlerDavid Amsellem | $19 | 12.8% upside | |
| 2024-01-23 | JefferiesGlen Santangelo | $14 |  16.9% downside | |
| 2022-11-14 | J.P. Morgan | $10 | 40.7% downside | |
| 2022-06-13 | UBSAshwani Verma | $10 | 40.7% downside | |
| 2022-05-04 | Piper Sandler | $7 | 58.5% downside | |
| 2022-04-20 | BarclaysBalaji Prasad | $13 | 22.8% downside | |